Clairvoyant Therapeutics Alternatives & Competitors

12 companies similar to Clairvoyant Therapeutics — Trailblazing a path to global mental health through psilocybin therapy

Emyria (ASX:EMD)

A clinical stage biotech informed by patient experience. Tackling unmet needs in neuroscie...

11 Post-IPO Equity $7.50M

Australia

Health Care Health and Wellness +1

Cybin Inc

We’re on a mission to revolutionize mental healthcare

73 Post-IPO Equity $398.53M

Toronto, Canada

Biotechnology Health Care +2

Journey Colab

We are on a mission to develop FDA-approved, psychedelic therapies, starting with syntheti...

14 Venture round $15.71M

San Francisco, United Sta...

Health Care Health and Wellness +1

Mindstate Design Labs

Precision design of therapeutic psychedelic states

22 Seed $11.63M

San Francisco, United Sta...

Biotechnology Health Care +1

Track all Clairvoyant Therapeutics competitors

Get real-time alerts when any of these companies raise funding, hire, or show growth signals.

See how it works

Adial Pharmaceuticals

Advancing addiction treatment with innovative medications and groundbreaking clinical tria...

11-50 Post-IPO Equity $30.22M

Biotechnology Health Care +1

Gilgamesh Pharmaceuticals

33 Grant $82.56M

New York, United States

Biotechnology Health Care +1

Courage Therapeutics

New hope for anorexia nervosa

3 Seed $1.00M

Newton, United States

Biotechnology Health Care +1

Euthymics Bioscience

Developing next-gen treatments for depression targeting those unmet by SSRIs

Series A $38.50M

Biotechnology Pharmaceutical

AGTC

Visionary science for life-changing cures.

117 Post-IPO Equity $195.05M

Alachua, United States

Biotechnology Health Care +1

Relmada Therapeutics, Inc

Relmada (Nasdaq: $RLMD) is a clinical-stage company developing novel therapies for the tre...

32 Post-IPO Equity

Coral Gables, United Stat...

Biotechnology Pharmaceutical

Global Blood Therapeutics

100 Post-IPO Debt $969.50M

South San Francisco, Unit...

Biotechnology Health and Wellness

ASLAN Pharmaceuticals

A clinical-stage immunology focused biopharmaceutical company.

44 IPO $218.00M

Singapore, Singapore

Biotechnology Health Care +1

About Clairvoyant Therapeutics

Clairvoyant Therapeutics is a trailblazing biotechnology startup dedicated to revolutionizing global mental health through psilocybin therapy. The company aims to provide evidence-based psychedelic therapy to patients with Alcohol Use Disorder (AUD), facilitating healthier and more enriched lives and stronger communiti...

Business keywords

Clinical Stage, Psychedelic Therapy, Psilocybin Therapy, Alcohol Use Disorder, Drug Development, Clinical Trials, Mental Health, Evidence-based Therapy, Double-blind Study, Global Expansion, Clinical Research, Treatment Innovation, Healthcare Advancement, Community Support

Frequently Asked Questions

Companies similar to Clairvoyant Therapeutics include Emyria (ASX:EMD), Cybin Inc, Journey Colab , Mindstate Design Labs, Adial Pharmaceuticals. They work in Biotechnology and Pharmaceutical and share Clairvoyant Therapeutics's focus on clinical trials, drug development and mental health.

Bounce Watch lists 12 companies that share Clairvoyant Therapeutics's industries and are closest to it in business tags, services, target customers, business model and size.

Don't just read about them. Follow them.

BounceWatch watches Clairvoyant Therapeutics and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.

See how it works

Explore Related

Clairvoyant Therapeutics Profile Emyria (ASX:EMD) Alternatives Cybin Inc Alternatives Journey Colab Alternatives All Companies All Signals Trend Reports

Compiled from the BounceWatch company index. We last looked at Clairvoyant Therapeutics on 12 Sep 2024. The 12 companies listed here were last checked between 11 Sep 2024 and 29 Sep 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.